A federal judge has allowed a pharmaceutical product-hopping lawsuit to move forward, forcing defendant Reckitt Benckiser to face allegations of antitrust violations.
The pharmaceutical company, which manufacturers a drug to treat opioid dependency, is accused of introducing “inconsequential changes” to the drug, changing it from a tablet placed under the tongue to a film placed under the tongue, in order to preserve the medicine’s exclusivity period.
Once that exclusivity period on the drug’s patent expires, the market is open for generic competition.
US District Judge Mitchell Goldberg ruled that while in general, the market benefits from the introduction of new products, the pharmaceutical industry is unique and, in this case, certain claims of antitrust violations are plausible. Judge Goldberg therefore ruled Wednesday to deny Reckitt Benckiser’s motion to dismiss.
The allegations accuse the company of so-called product-hopping.
”Although the issue of product-hopping is relatively novel,” Judge Goldberg said, “what is clear form the case law is that simply introducing a new product on the market, whether it is a superior product or not, does not, by itself, constitute exclusionary conduct.”
Full content: The Intelligencer
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI